Estrogen-cholinergic interactions: Implications for cognitive aging

Hormones and Behavior

Volumn 74, Issue , 2015, Pages 173-185

  Newhouse, Paul ^a,b   Dumas, Julie ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Acetylcholine; Attention; Brain imaging; Cognitive performance; Estradiol; Memory

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL; MECAMYLAMINE; PLACEBO; SCOPOLAMINE; TAMOXIFEN; ACETYLCHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT;

AGING; ARTICLE; ATTENTION; BREAST CANCER; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COGNITION; ESTROGEN ACTIVITY; FOREBRAIN; FUNCTIONAL NEUROIMAGING; HORMONAL THERAPY; HUMAN; LEARNING; MEMORY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TASK PERFORMANCE; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY; AGED; BRAIN; CHOLINERGIC NERVE CELL; COGNITIVE AGING; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE; PHYSIOLOGY; SHORT TERM MEMORY;

ACETYLCHOLINE; AGED; ATTENTION; BRAIN; CHOLINERGIC AGENTS; CHOLINERGIC NEURONS; COGNITION; COGNITIVE AGING; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEARNING; MEMORY, SHORT-TERM; TAMOXIFEN;

EID: 84941747972     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2015.06.022     Document Type: Article

References (179)

1. Ábrahám I.M., Koszegi Z., Tolod-Kemp E., Szego É.M. Action of estrogen on survival of basal forebrain cholinergic neurons: promoting amelioration. Psychoneuroendocrinology 2009, 34:S104-S112.
2. Acosta J.I., Mayer L., Talboom J.S., Tsang C.W.S., Smith C.J., Enders C.K., Bimonte-Nelson H.A. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology 2009, 150:4248-4259.
3. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:270-279.
4. Alhola P., Polo-Kantola P., Erkkola R., Portin R. Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women. Neurology 2007, 67:706-709.
5. Almeida O.P., Lautenschlager N.T., Vasikaran S., Leedman P., Gelavis A., Flicker L. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70years and older: effect on mood, cognition, and quality of life. Neurobiol. Aging 2006, 27:141-149.
6. Astur R.S., Taylor L.B., Mamelak A.N., Philpott L., Sutherland R.J. Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav. Brain Res. 2002, 132:77-84.
7. Baddeley A.D. Working Memory 1986, Clarendon Press, Oxford.
8. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. J. Am. Med. Assoc. 1993, 269:2637-2641.
9. Bentley P., Husain M.K., Dolan R.J. Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron 2004, 41:969-982.
10. Binder E.F., Schechtman K.B., Birge S.J., Williams D.B., Kohrt W.M. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 2001, 38:137-146.
11. Boele F.W., Schilder C.M.T., de Roode M.-L., Deijen J.B., Schagen S.B. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause 2015, 22:17-25.
12. Bora S.H., Liu Z., Kecojevic A., Merchenthaler I., Koliatsos V.E. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Exp. Neurol. 2005, 194:506-522.
13. Bretsky P.M., Buckwalter J.G., Seeman T.E., Miller C.A., Poirier J., Schellenberg G.D., Finch C.E., Henderson V.W. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease. Alzheimer Dis. Assoc. Disord. 1999, 13:216-221.
14. Brinton R.D. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?. CNS Drugs 2004, 18:405-422.
15. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci. 2008, 31:529-537.
16. Buckwalter J.G., Crooks V.C., Robins S.B., Petitti D.B. Hormone use and cognitive performance in women of advanced age. J. Am. Geriatr. Soc. 2004, 52:182-186.
17. Cabeza R., Anderson N.D., Locantore J.K., McIntosh A.R. Aging gracefully: compensatory brain activity in high-performing older adults. NeuroImage 2002, 17:1394-1402.
18. Cabeza R., Daselaar S.M., Dolcos F., Prince S.E., Budde M., Nyberg L. Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic memory retrieval. Cereb. Cortex 2004, 14:364-375.
19. Cardoso C.C., Ricardo V.P., Frussa-Filho R., Porto C.S., Abdalla F.M.F. Effects of 17β-estradiol on expression of muscarinic acetylcholine receptor subtypes and estrogen receptor α in rat hippocampus. Eur. J. Pharmacol. 2010, 634:192-200.
20. Carter C.L., Resnick E.M., Mallampalli M., Kalbarczyk A. Sex and gender differences in Alzheimer's disease: recommendations for future research. J. Womens Health (Larchmt) 2012, 21:1018-1023.
21. Chalbos D., Philips A., Rochefort H. Genomic cross-talk between the estrogen receptor and growth factor regulatory pathways in estrogen target tissues. Cancer Biol. 1994, 5:361-368.
22. Coker L.H., Espeland M.A., Rapp S.R., Legault C., Resnick S.M., Hogan P., Gaussoin S., Dailey M., Shumaker S.A. Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J. Steroid Biochem. Mol. Biol. 2010, 118:304-310.
23. Coppus A.M., Evenhuis H.M., Verberne G.J., Visser F.E., Eikelenboom P., van Gool W.A., Janssens A.C., van Duijn C.M. Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome. J. Alzheimers Dis. 2010, 19:545-550.
24. Craig L.A., Hong N.S., McDonald R.J. Revisiting the cholinergic hypothesis in the development of Alzheimer's disease. Neurosci. Biobehav. Rev. 2011, 35:1397-1409.
25. Daniel J.M. Estrogens, estrogen receptors, and female cognitive aging: the impact of timing. Horm. Behav. 2013, 63:231-237.
26. Daniel J.M., Hulst J.L., Lee C.D. Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience 2005, 132:57-64.
27. Daniel J.M., Hulst J.L., Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats whine initiated immediately after ovariectomy but not after a lone-term period of ovarian hormone deprivation. Endocrinology 2006, 147:607-614.
28. Daselaar S.M., Veltman D.J., Rombouts S., Raaijmakers J., Jonker C. Neuroanatomical correlates of episodic encoding and retrieval in young and elderly subjects. Brain 2003, 126:43-56.
29. Davis S.W., Dennis N.A., Daselaar S.M., Fleck M.S., Cabeza R. Que PASA? The Posterior Anterior Shift in Aging. Cereb. Cortex 2008, 18:1201-1209.
30. Ditkoff E.C., Crary W.G., Cristo M., Lobo R.A. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet. Gynecol. 1991, 78:991-995.
31. Dohanich G.P., Witcher J.A., Weaver D.R., Clemens L.G. Alteration of muscarinic binding in specific brain areas following estrogen treatment. Brain Res. 1982, 241:347-350.
32. Dohanich G.P., Fader A.J., Javorsky D.J. Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats. Behav. Neurosci. 1994, 108:988-992.
33. Duka T., Tasker R., McGowan J.F. The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 2000, 149:129-139.
34. Dumas J.A., Newhouse P.A. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol. Biochem. Behav. 2011, 99:254-261.
35. Dumas J.A., Hancur-Bucci C., Naylor M., Sites C., Newhouse P.A. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal post-menopausal women. Neuropsychopharmacology 2006, 31:2065-2078.
36. Dumas J., Hancur-Bucci C., Naylor M., Sites C., Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 2008, 53:159-169.
37. Dumas J.A., Saykin A.J., McDonald B.C., McAllister T.W., Hynes M.L., Newhouse P.A. Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. Am. J. Geriatr. Psychiatr. 2008, 16:272-282.
38. Dumas J.A., McDonald B.C., Saykin A.J., McAllister T.W., Hynes M.L., West J.D., Newhouse P.A. Cholinergic modulation of hippocampal activity during episodic memory encoding in postmenopausal women: a pilot study. Menopause 2010, 17:852-859.
39. Dumas J.A., Kutz A.M., Naylor M.R., Johnson J.V., Newhouse P.A. Increased memory load-related frontal activation after estradiol treatment in postmenopausal women. Horm. Behav. 2010, 58:929-935.
40. Dumas J.A., Kutz A.M., Naylor M.R., Johnson J.V., Newhouse P.A. Estradiol treatment altered anticholinergic-related brain activation during working memory in postmenopausal women. NeuroImage 2012, 60:1394-1403.
41. Dumas J.A., Kutz A.M., McDonald B.C., Naylor M.R., Pfaff A.C., Saykin A.J., Newhouse P.A. Increased working memory-related brain activity in middle-aged women with cognitive complaints. Neurobiol. Aging 2013, 34:1145-1147.
42. Espeland M.A., Rapp S.R., Shumaker S., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J. Conjugated equine estrogen and global cognitive function in postmenopausal women. J. Am. Med. Assoc. 2004, 291:2959-2967.
43. Fader A.J., Johnson P.E.M., Dohanich G.P. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine on a radial-arm maze. Pharmacol. Biochem. Behav. 1999, 62:711-717.
44. Farr S.A., Banks W.A., Morley J.E. Estradiol potentiates acetylcholine and glutamate-mediated post-trial memory processing in the hippocampus. Brain Res. 2000, 864:263-269.
45. Fernandez J.W., Grizzell J.A., Wecker L. The role of estrogen receptor β and nicotinic cholinergic receptors in postpartum depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2013, 40:199-206.
46. Fillit H. Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women. Ann. N. Y. Acad. Sci. 1994, 233-238.
47. Foster T.C., Sharrow K.M., Kumar A., Masse J. Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol. Aging 2003, 24:839-852.
48. Furey M.L., Pietrini P., Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 2000, 290:2315-2319.
49. Gazzaley A., Cooney J.W., Rissman J., D'Esposito M. Top-down suppression deficit underlies working memory impairment in normal aging. Nat. Neurosci. 2005, 8:1298-1300.
50. Gibbs R.B. Estrogen and nerve growth factor - related systems in brain. Ann. N. Y. Acad. Sci. 1994, 743:165-196.
51. Gibbs R.B. Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: effects of estrogen and progesterone. J. Neurosci. 1996, 16:1049-1055.
52. Gibbs R.B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 1998, 151:289-302.
53. Gibbs R.B. Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Horm. Behav. 1999, 36:222-233.
54. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101:931-938.
55. Gibbs R.B. Estrogen enhancement of learning requires intact basal forebrain cholinergic neutrons. Soc. Neurosci. Abstr. 2001, 31:312.
56. Gibbs R.B. Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocr. Rev. 2010, 31:224-253.
57. Gibbs R.B., Wu D., Hersh L.B., Pfaff D.W. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 1994, 129:70-80.
58. Gibbs R.B., Nelson D., Hammond R. Role of GPR30 in mediating estradiol effects on acetylcholine release in the hippocampus. Horm. Behav. 2014, 66:339-345.
59. Gould E., Woolley C.S., Frankfurt M., McEwen B.S. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 1990, 10:1286-1291.
60. Greendale G.A., Huang M.-H., Wight R.G., Seeman T., Luetters C., Avis N.E., Johnston J., Karlamangla A.S. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 2009, 72:1850-1857.
61. Halbreich U., Lumley L.A., Palter S., Manning C., Gengo F., Joe S.H. Possible acceleration of age effects on cognition following menopause. J. Psychiatr. Res. 1995, 29:153-163.
62. Hammond R., Gibbs R.B. GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance. Brain Res. 2011, 1379:53-60.
63. Hammond R., Nelson D., Gibbs R.B. GPR30 co-localizes with cholinergic neurons in the basal forebrain and enhances potassium-stimulated acetylcholine release in the hippocampus. Psychoneuroendocrinology 2011, 36:182-192.
64. Harman S.M., Brinton E.A., Clarkson T., Heward C.B., Hecht H.S., Karas R.H. Is the WHI relevant to HRT started in the perimenopause?. Endocrine 2004, 24:195-202.
65. Hasselmo M.E., Sarter M. Modes and models of forebrain cholinergic neuromodulation of cognition. Neuropsychopharmacology 2011, 36:52-73.
66. Haun F., Drott J., Ruben A., Kolb B. Tamoxifen both reduces and prevents cognitive deficits and increases synaptic space in the cortex of aged female rats. Soc. Neurosci. 2001, 31:247.210.
67. Haynes B., Dowsett M. Clinical pharmacology of selective estrogen receptor modulators. Drugs Aging 1999, 14:323-336.
68. Henderson V.W., Paganini-Hill A., Miller B.L., Elble R.J., Reyes P.F., Shoupe D., McCleary C.A., Klein R.A., Hake A.M., Farlow M.R. Estrogen for Alzheimer's disease in women. Randomized, double-blind, placebo-controlled trial. Neurology 2000, 54:295-301.
69. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., Farrer L.A. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J. Neurol. Neurosurg. Psychiatry 2005, 76:103-105.
70. Hogervorst E., Bandelow S. Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials. Maturitas 2010, 66:56-71.
71. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognition function in post-menopausal women: a meta-analysis. Neuroscience 2000, 101:485-512.
72. Jacobs D.M., Tang M.X., Stern Y., Sano M., Marder K., Bell K.L., Schofield P., Dooneief G., Gurland B., Mayeux R. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998, 50:368-373.
73. Jacobs E.G., Kroenke C., Lin J., Epel E.S., Kenna H.A., Blackburn E.H., Rasgon N.L. Accelerated cell aging in female APOE-ε4 carriers: implications for hormone therapy use. PLoS ONE 2013, 8:e54713.
74. Janelsins M.C., Kesler S.R., Ahles T.A., Morrow G.R. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int. Rev. Psychiatry 2014, 26:102-113.
75. Jessen F., Wolfsgruber S., Wiese B., Bickel H., Mösch E., Kaduszkiewicz H., Pentzek M., Riedel-Heller S.G., Luck T., Fuchs A., Weyerer S., Werle J., van den Bussche H., Scherer M., Maier W., Wagner M. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimers Dement. 2014, 10:76-83.
76. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., Martin K.A. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13:411-422.
77. Kandi P., Hayslett R.L. Nicotine and 17β-estradiol produce an antidepressant-like effect in female ovariectomized rats. Brain Res. Bull. 2011, 84:224-228.
78. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. Neurology 1997, 48:1517-1521.
79. Keenan P.A., Ezzat W.H., Ginsburg K., Moore G.J. Prefrontal cortex as the site of estrogen's affect on cognition. Psychoneuroendocrinology 2001, 26:577-590.
80. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm. Behav. 1995, 29:312-321.
81. Kow L.M., Pfaff D.W. Estrogen effects on neural responsiveness to electrical and neurotransmitter stimulation: an in vitro study on the ventromedial nucleus of the hypothalamus. Brain Res. 1985, 347:1-10.
82. Krug R., Born J., Rasch B. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology 2006, 31:965-975.
83. Labouvie-Vief G. Dynamic integration: affect, cognition, and the self in adulthood. Curr. Dir. Psychol. Sci. 2003, 12:201-206.
84. Lacreuse A. Effects of ovarian hormones on cognitive function in nonhuman primates. Neuroscience 2006, 138:859-867.
85. Lacreuse A., Wilson M.E., Herndon J.G. Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol. Aging 2002, 23:589-600.
86. LeBlanc E.S., Janowsky J., Chan B.K.S., Nelson H.D. Hormone replacement therapy and cognition: systematic review and meta-analysis. J. Am. Med. Assoc. 2001, 285:1489-1499.
87. LeBlanc E.S., Neiss M.B., Carello P.E., Samuels M.H., Janowsky J.S. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 2007, 14:191-202.
88. Lee S.J., McEwen B.S. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 2001, 41:569-591.
89. Levey A.I. Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc. Natl. Acad. Sci. 1996, 93:13541-13546.
90. Light L.L. Memory and aging: four hypotheses in search of data. Annu. Rev. Psychol. 1991, 42:333-376.
91. Luine V.N., Rhodes J.C. Gonadal hormone regulation of MAO and other enzymes in hypothalamic areas. Neuroendocrinology 1983, 36:235-241.
92. Luine V.N., Khylchevskaya R.I., McEwen B.S. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975, 86:293-306.
93. Luine V.N., Renner K.J., McEwen B.S. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments. Endocrinology 1986, 119:874-878.
94. MacLennan A.H., Henderson V.W., Paine B.J., Mathia J., Ramsay E.N., Ryan P., Stocks N.P., Taylor A.W. Hormone therapy, timing of initiation, and cognition in women aged older than 60years: the REMEMBER pilot study. Menopause 2006, 13:28-36.
95. Maki P.M. Estrogen effects on the hippocampus and frontal lobes. Int. J. Fertil. Womens Med. 2005, 50:67-71.
96. Maki P.M. A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann. N. Y. Acad. Sci. 2005, 1052:182-197.
97. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138:1027-1030.
98. Maki P., Hogervorst E. HRT and cognitive decline. Best Pract. Res. Clin. Endocrinol. Metab. 2003, 17:105-122.
99. McMillan P.J., Singer C.A., Dorsa D.M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 1996, 16:1860-1865.
100. Mennenga S.E., Gerson J.E., Koebele S.V., Kingston M.L., Tsang C.W.S., Engler-Chiurazzi E.B., Baxter L.C., Bimonte-Nelson H.A. Understanding the cognitive impact of the contraceptive estrogen ethinyl estradiol: tonic and cyclic administration impairs memory, and performance correlates with basal forebrain cholinergic system integrity. Psychoneuroendocrinology 2015, 54:1-13.
101. Miettinen R.A., Kalesnykas G., Koivisto E.H. Estimation of the total number of cholinergic neurons containing estrogen receptor-a in the rat basal forebrain. J. Histochem. Cytochem. 2002, 50:891-902.
102. Miller M.M., Hyder M., Assag R., Panarella R., Tousignant P., Franklin K.B.J. Estrogen modulates spontaneous alternation and to the cholinergic phenotype in the basal forebrain. Neuroscience 1999, 91:1143-1153.
103. Morcom A.M., Good C.D., Frackowiak R.S.J., Rugg M.D. Age effects on the neural correlates of successful memory encoding. Brain 2003, 126:213-229.
104. Morley B.J., Rodriguez-Sierra J.F., Clough R.W. Increase in hypothalamic nicotine acetylcholine receptors in prepubertal female rats administered estrogen. Brain Res. 1983, 278:262-265.
105. Mufson E.J., Ma S.Y., Dills J., Cochran E.J., Leurgans S., Wuu J., Bennett D.A., Jaffar S., Gilmor M.L., Levey A.I., Kordower J.H. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 2002, 443:136-153.
106. Mulnard R.A., Cotman C.W., Kawas C., van Dyck C.H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A., Grundman M., Thomas R., Thal L.J. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. J. Am. Med. Assoc. 2000, 283:1007-1015.
107. Newhouse P.A., Sunderland T., Tariot P.N., Weingartner H., Thomason K., Mellow A.M., Cohen R.M., Murphy D.L. The effects of acute scopolamine in geriatric depression. Arch. Gen. Psychiatry 1988, 45:906-912.
108. Newhouse P.A., Newhouse C., Astur R.S. Sex differences and visuospatial learning using a virtual maze in pre-pubertal children. Behav. Brain Res. 2007, 183:1-7.
109. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Biol. Psychiatry 2001, 49:268-278.
110. Newhouse P.A., Potter A.S., Dumas J.A., Thiel C.M. Functional brain imaging of nicotinic effects on higher cognitive processes. Biochem. Pharmacol. 2011, 82:943-951.
111. Newhouse P., Albert K., Astur R., Johnson J., Naylor M., Dumas J.A. Tamoxifen improves cholinergically-modulated cognitive performance in postmenopausal women. Neuropsychopharmacology 2013, 38:2632-2643.
112. Norbury R., Travis M.J., Erlandsson K., Waddington W., Ell P.J., Murphy D.G.M. Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study. Horm. Behav. 2007, 51:249-257.
113. Ohkura T., Isse K., Akawaz K. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocr. J. 1994, 41:361-371.
114. Paganini-Hill A., Henderson V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 1994, 140:256-261.
115. Panidis D.K., Matalliotakis I.M., Rousso D.H., Kourtis A.I., Koumantakis E.E. The role of estrogen replacement therapy in Alzheimer's disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 2001, 95:86-91.
116. Pefanco M.A., Kenny A.M., Kaplan R.F., Kuchel G., Walsh S., Kleppinger A., Prestwood K. The effect of 3-year treatment with 0.25mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women. J. Am. Geriatr. Soc. 2007, 55:426-431.
117. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17:485-495.
118. Pines A. Postmenopausal hormone therapy: the way ahead. Maturitas 2007, 57:3-5.
119. Pinkerton J.V., Henderson V.W. Estrogen and cognition, with a focus on Alzheimer's disease. Semin. Reprod. Med. 2005, 23:172-179.
120. Polo-Kantola P., Portin R., Polo O., Helenius H., Irjala K., Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet. Gynecol. 1998, 91:459-466.
121. Rapp P.R., Morrison J.H., Roberts J.A. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J. Neurosci. 2003, 23:5708-5714.
122. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L.S., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. J. Am. Med. Assoc. 2003, 289:2663-2672.
123. Reisberg B., Shulman M.B., Torossian C., Leng L., Zhu W. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement. 2010, 6:11-24.
124. Resnick S.M., Henderson V.W. Hormone therapy and risk of Alzheimer disease: a critical time. J. Am. Med. Assoc. 2002, 288:2170-2172.
125. Resnick S.M., Metter E.J., Zonderman A.B. Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect. Neurology 1997, 49:1491-1497.
126. Risacher S.L., Kim S., Shen L., Nho K., Foroud T., Green R.C., Petersen R.C., Jack C.R., Aisen P.S., Koeppe R.A., Jagust W.J., Shaw L.M., Trojanowski J.Q., Weiner M.W., Saykin A.J., Alzheimer's Disease Neuroimaging Initiative d. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front. Aging Neurosci. 2013, 5:11.
127. Rodda J.E., Dannhauser T.M., Cutinha D.J., Shergill S.S., Walker Z. Subjective cognitive impairment: increased prefrontal cortex activation compared to controls during an encoding task. Int. J. Geriatr. Psychiatry 2009, 24:865-874.
128. Rodda J., Dannhauser T., Cutinha D.J., Shergill S.S., Walker Z. Subjective cognitive impairment: functional MRI during a divided attention task. Eur. Psychiatry 2011, 26:457-462.
129. Roses A.D. Apolipoprotein E affects the rate of Alzheimer disease expression: b-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol. 1994, 53:429-437.
130. Rypma B., D'Esposito M. Isolating the neural mechanisms of age-related changes in human working memory. Nat. Neurosci. 2000, 3:509-515.
131. Sarter M., Hasselmo M.E., Bruno J.P., Givens B. Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection. Brain Res. Rev. 2005, 48:98-111.
132. Savonenko A.V., Markowska A.L. The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience 2003, 821-830.
133. Saykin A.J., Wishart H.A., Rabin L.A., Santulli R.B., Flashman L.A., West J.D., McHugh T.L., Mamourian A.C. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006, 67:834-842.
134. Schilder C.M., Eggens P.C., Seynaeve C., Linn S.C., Boogerd W., Gundy C.M., Beex L.V., van Dam F.S.A.M., Schagen S.B. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol. 2009, 48:76-85.
135. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 1996, 46:1580-1584.
136. Shaywitz S.E., Shaywitz B.A., Pugh K.R., Fulbright R.K., Skudlarski P., Mencl W.E., Constable R.T., Naftolin F., Palter S.F., Marchione K.E., Katz L., Shankweiler D.P., Fletcher J.M., Lacadie C., Keltz M., Gore J.C. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999, 281:1197-1202.
137. Shaywitz S.E., Naftolin F., Zelterman D., Marchione K.E., Holahan J.M., Palter S.F., Shaywitz B.A. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003, 10:420-426.
138. Sherwin B.B. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988, 13:345-357.
139. Sherwin B.B. Hormones, mood, and cognitive functioning in postmenopausal women. Obstet. Gynecol. 1993, 87:20S-26S.
140. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 2006, 138:1021-1026.
141. Sherwin B.B. The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature. J. Neuroendocrinol. 2007, 19:77-81.
142. Shughrue P.J., Scrimo P.J., Merchenthaler I. Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain. Neuroscience 2000, 96:41-49.
143. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. J. Am. Med. Assoc. 2003, 289:2651-2662.
144. Silva I., Mello L.E., Freymüller E., Haidar M.A., Baracat E.C. Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats. Menopause 2003, 10:406-411.
145. Singh M., Meyer E.M., Huang F.S., Millard W.J., Simpkins J.W. Ovariectomy reduced ChAT activity and NGF mRNA levels in the frontal cortex and hippocampus of the female Sprague-Dawley rat. Soc. Neurosci. Abstr. 1993, 19:514.
146. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994, 644:305-312.
147. Singh M., Meyer E.M., Simpkins J.W. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor mRNA expression in brain regions of female Sprague-Dawley rats. Endocrinology 1995, 136:2320-2324.
148. Singh M., Simpkins J.W., Bimonte-Nelson H.A., Brinton R.D. Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Brain Res. 2013, 1514:1-2.
149. Smith Y.R., Giordani B., Lajiness-O'Neill R., Zubieta J. Long-term estrogen replacement is associated with improved nonverbal memory and attentional measures in postmenopausal women. Fertil. Steril. 2001, 76:1101-1107.
150. Smith Y.R., Minoshima S., Kuhl D.E., Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 2001, 86:679-684.
151. Smith Y.R., Love T., Persad C.C., Tkaczyk A., Nicols T.E., Zubieta J.K. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J. Clin. Endocrinol. Metab. 2006, 91:4476-4481.
152. Smith Y.R., Bowen L., Love T.M., Berent-Spillson A., Frey K.A., Persad C.C., Reame N.K., Koeppe R.A., Zubieta J.-K. Early initiation of hormone therapy in menopausal women is associated with increased hippocampal and posterior cingulate cholinergic activity. J. Clin. Endocrinol. Metab. 2011, 96:E1761-E1770.
153. Sperling R., Greve D., Dale A., Killiany R., Holmes J., Rosas H.D., Cocchiaro A., Rosen B., Lake S., Lange N., Routledge C., Albert M. Functional MRI detection of pharmacologically induced memory impairment. Proc. Natl. Acad. Sci. 2002, 99:455-460.
154. Stevens M.C., Clark V.P., Prestwood K.M. Low-dose estradiol alters brain activity. Psychiatry Res. 2005, 139:199-217.
155. Sunderland T., Tariot P., Weingartner H., Murphy D., Newhouse P., Mueller E., Cohen R. Pharmacologic modeling of Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 1986, 10:599-610.
156. Sunderland T., Tariot P.N., Newhouse P.A. Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res. Rev. 1988, 13:371-389.
157. Szego E.M., Barabas K., Balog J., Szilagyi N., Korach K.S., Juhasz G., Abraham I.M. Estrogen induces estrogen receptor alpha-dependent cAMP response element-binding protein phosphorylation via mitogen activated protein kinase pathway in basal forebrain cholinergic neurons in vivo. J. Neurosci. 2006, 26:4104-4110.
158. Tanabe F., Miyasaka N., Kubota T., Aso T. Estrogen and progesterone improve scopolamine-induced impairment of spatial memory. J. Med. Dent. Sci. 2004, 51:89-98.
159. Tanaka K., Tamura T., Kawashima M., Ueda S., Matsumoto Y., Kawata M., Ogino Y., Yamamoto T., Honjo H., Okada H. The histochemical study of the effects of estrogen on the forebrain cholinergic neurons of fetal female rats transplanted into the anterior eye chamber of adult female rats. Folia Endocrinol. Jpn. 1993, 69:534-540.
160. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996, 348:429-432.
161. Thiel C.M. Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging. Neurobiol. Learn. Mem. 2003, 80:234-244.
162. Thiel C.M., Zilles K., Fink G.R. Cholinergic Modulation of Visuospatial Attention: An Event-related fMRI Study With Pharmacological Challenge 2003.
163. Tinkler G.P., Voytko M.L. Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2005, 29:423-431.
164. Toran-Allerand C.D. The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?. Dev. Neurosci. 1996, 18:36-48.
165. Tulving E., Kapur S., Craik F.I., Moscovitch M., Houle S. Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. Proc. Natl. Acad. Sci. 1994, 91:2016-2020.
166. Verghese J., Kuslansky G., Katz M.J., Sliwinski M., Crystal H.A., Buschke H., Lipton R.B. Cognitive performance in surgically menopausal women on estrogen. Neurology 2000, 55:872-874.
167. Verhaeghen P., Cerella J. Aging, executive control, and attention: a review of meta-analyses. Neurosci. Biobehav. Rev. 2002, 26:849-857.
168. Verhaeghen P., Marcoen A., Goossens L. Facts and fiction about memory aging: a quantitative integration of research findings. J. Gerontol. 1993, 48:P157-P171.
169. Voytko M.L., Higgs C.J., Murray R. Differential effects on visual and spatial recognition memory of a novel hormone therapy regimen of estrogen alone or combined with progesterone in older surgically menopausal monkeys. Neuroscience 2008, 154:1205-1217.
170. Weber M., Mapstone M. Memory complaints and memory performance in the menopausal transition. Menopause 2009, 16:1-7.
171. Weber M.T., Rubin L.H., Maki P.M. Cognition in perimenopause: the effect of transition stage. Menopause 2013, 20:511-517.
172. Woods N.F., Mitchell E.S., Adams C. Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause 2000, 7:257-265.
173. Woolley C.S., McEwen B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 1993, 336:293-306.
174. Yaffe K. Hormone therapy and the brain: déjà vu all over again?. J. Am. Med. Assoc. 2003, 289:2717-2719.
175. Yaffe K., Lui L., Grady D., Massa S., Stone K., Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol. Psychiatry 2002, 51:677-682.
176. Yaffe K., Vittinghoff E., Ensrud K.E., Johnson K.C., Diem S., Hanes V., Grady D. Effects of ultra-low dose transdermal estradiol on cognition and health-related quality of life. Arch. Neurol. 2006, 63:945-950.
177. Yamamoto H., Kitawaki J., Kikuchi N., Okubo T., Iwasa K., Kawata M., Honjo H. Effects of estrogens on cholinergic neurons in the rat basal nucleus. J. Steroid Biochem. Mol. Biol. 2007, 107:70-79.
178. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., Breitner J.C.S. Hormone replacement therapy and incidence of Alzheimer disease in older women. J. Am. Med. Assoc. 2002, 288:2123-2129.
179. Zhou J., Zhang H., Cohen R.S., Pandey S.C. Effects of estrogen treatment on expression of BDNF and CREB expression and phosphorylation in rat amygdaloid and hippocampal structures. Neuroendocrinology 2005, 81:294-310.